Prostaglandin E2 increases the expression of cyclooxygenase-2 in cultured rat microglia

J Neuroimmunol. 2021 Dec 15:361:577724. doi: 10.1016/j.jneuroim.2021.577724. Epub 2021 Sep 23.

Abstract

Prostaglandin E2 (PGE2) plays pivotal roles in controlling microglial activation with the EP2 receptor, a PGE2 receptor subtype. Activated microglia are often reported to increase cyclooxygenase (COX)-2 expression, followed by PGE2 production, but it is unclear whether extracellular PGE2 is involved in microglial PGE2 synthesis. In the present study, we report that PGE2 increases COX-2 protein in microglia. In a culture system, PGE2 at 10-6 M for 3 h increased COX-2 and microsomal PGE synthase (mPGES)-1 mRNA levels, and reduced mPGES-2, but did not affect COX-1 or cytosolic PGE synthase (cPGES) in microglia. PGE2 at 10-6 M for 3 h also increased the COX-2 protein level, but did not affect COX-1, mPGES-1, mPGES-2, or cPGES. An EP2 agonist, ONO-AE1-259-01, also increased COX-2 and mPGES-1 mRNA levels, and reduced mPGES-2, but did not affect COX-1 or cPGES, whereas an EP1 agonist, ONO-DI-004, an EP3 agonist, ONO-AE-248, and an EP4 agonist, ONO-AE1-329, had no effect. Similar to PGE2, ONO-AE1-259-01 increased the COX-2 protein level, but did not affect COX-1, mPGES-1, mPGES-2, or cPGES. In addition, the effects of PGE2 were inhibited by an EP2 antagonist, PF-04418948, but not by an EP1 antagonist, ONO-8713, an EP3 antagonist, ONO-AE3-240, or an EP4 antagonist, ONO-AE3-208, at 10-6 M. On the other hand, lipopolysaccharide (LPS) increased PGE2 production, but the LPS-induced PGE2 production was not affected by ONO-8713, PF-04418948, ONO-AE3-240, or ONO-AE3-208. These results indicate that PGE2 increases COX-2 protein in microglia through the EP2 receptor supporting the idea that extracellular PGE2 has a triggering aspect for microglial activation.

Keywords: Microglia; PGE(2); Ptger2; Ptges; Ptgs2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Azetidines / pharmacology
  • Cells, Cultured
  • Cerebral Cortex / cytology
  • Cyclooxygenase 1 / biosynthesis
  • Cyclooxygenase 1 / genetics
  • Cyclooxygenase 2 / biosynthesis*
  • Cyclooxygenase 2 / genetics
  • Dinoprostone / analogs & derivatives
  • Dinoprostone / biosynthesis
  • Dinoprostone / pharmacology*
  • Enzyme Induction / drug effects
  • Membrane Proteins / biosynthesis
  • Membrane Proteins / genetics
  • Methyl Ethers / pharmacology
  • Microglia / drug effects*
  • Microglia / enzymology
  • Microsomes / drug effects
  • Microsomes / enzymology
  • Prostaglandin-E Synthases / biosynthesis
  • Prostaglandin-E Synthases / genetics
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Rats
  • Rats, Wistar
  • Receptors, Prostaglandin E, EP2 Subtype / agonists
  • Receptors, Prostaglandin E, EP2 Subtype / antagonists & inhibitors

Substances

  • 11,15-O-dimethylprostaglandin E2
  • Azetidines
  • Membrane Proteins
  • Methyl Ethers
  • ONO-AE1-329
  • RNA, Messenger
  • Receptors, Prostaglandin E, EP2 Subtype
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Ptgs1 protein, rat
  • Ptgs2 protein, rat
  • Prostaglandin-E Synthases
  • Ptges protein, rat
  • 1-(4-fluorobenzoyl)-3-(((6-methoxy-2-naphthyl)oxy)methyl)azetidine-3-carboxylic acid
  • Dinoprostone